while in the fast evolving area of oncology research, exact and efficient mutation screening is essential for developing specific therapies. The KRAS products and services Platform plays a pivotal position Within this landscape by featuring in depth methods for KRAS mutation profiling and analysis. KRAS mutations, located in around ninety five% of